APPENDIX 2
Public Hearing
Monday,
29 April 2013
Mantra Hotel, 222 Russell Street, Melbourne
Witnesses
Dr Kenneth Harvey
Australian Medical
Association (via teleconference)
Dr
Steven Hambleton, Federal President
Medicines Australia
Ms
Deborah Monk, Director Innovation and Industry Policy
Dr
Dominic Barnes, Chair, Transparency Working Group
GlaxoSmithKline
Mr
Geoff McDonald, General Manager and Board Member, Medicines Australia
Ms Lisa
Maguire, Associate Director, Corporate Affairs
Department of Health and
Ageing
Mr
Peter Woodley, Assistant Secretary, Blood, Organ and Regulatory Policy Branch,
Regulatory Policy and Governance
Therapeutic Goods
Administration
Ms
Philippa Horner PSM, Principal Legal Adviser
Navigation: Previous Page | Contents